(19)
(11) EP 1 244 786 A1

(12)

(43) Date of publication:
02.10.2002 Bulletin 2002/40

(21) Application number: 00988766.2

(22) Date of filing: 30.11.2000
(51) International Patent Classification (IPC)7C12N 15/12, C07K 14/47, A61K 38/17
(86) International application number:
PCT/EP0011/997
(87) International publication number:
WO 0104/0460 (07.06.2001 Gazette 2001/23)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 01.12.1999 GB 9928430

(71) Applicant: GLAXO GROUP LIMITED
Greenford, Middlesex UB6 ONN (GB)

(72) Inventors:
  • BRADDOCK, MartinGlaxo Wellcome PLC
    StevenageHertfordshire SG1 2NY (GB)
  • CAMPBELL, Callum Jeffrey,Glaxo Wellcome PLC
    StevenageHertfordshire SN1 2NY (GB)

(74) Representative: Crawley, Karen Anne 
GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) SCREENING METHOD FOR COMPOUNDS CAPABLE OF MODULARING EGR-1-REGULATED EXPRESSION